Core Viewpoint - Gevo, Inc. is planning an expansion of its North Dakota facility to add a second ethanol production facility with a targeted capacity of up to 75 million gallons per year of low-carbon ethanol, aiming to solidify its leadership in the low-carbon fuel market and support U.S. energy independence [1][4]. Group 1: Expansion Plans - The expansion at the Gevo North Dakota facility is a strategic priority for the company, leveraging existing infrastructure and local agricultural productivity to enhance production efficiency and reduce risks [2][4]. - The GND site is expected to produce approximately 150 million gallons per year of low-carbon ethanol, capture over 400,000 metric tons of CO₂, and generate additional coproducts such as animal feed and corn oil [3]. Group 2: Carbon Management and Revenue Generation - The integrated system at GND combines ethanol production with CO₂ capture and permanent sequestration, allowing Gevo to monetize carbon in voluntary markets and generate revenue through low-carbon fuel production [2][3]. - The captured CO₂ can be utilized for various industrial applications, including enhanced oil recovery, or sequestered for carbon-removal credits, aligning with the company's long-term growth objectives [3]. Group 3: Market Position and Future Opportunities - Gevo anticipates that the expansion will meet the growing demand for low-carbon ethanol both domestically and internationally, while also laying the groundwork for future large-scale synthetic aviation fuel opportunities [4]. - The company is receiving interest from multiple potential financiers, indicating confidence in its expansion plans and the strategic value of the project [4]. Group 4: Commitment to Sustainability - Gevo is committed to producing cost-effective, drop-in fuels that enhance energy security, reduce carbon emissions, and support rural economic growth [5]. - The company operates an ethanol plant with adjacent carbon capture and storage facilities, and is developing the world's first large-scale alcohol-to-jet facility at its North Dakota site [5].

Financing Agreements - KH Group has signed secured financing agreements totaling EUR 33.5 million, which includes EUR 20.5 million in term loans and EUR 13.0 million in revolving credit facilities [1] - The financing agreements have a term of two years with an option for a one-year extension, subject to the consent of the financing providers [1] - The new financing arrangement replaces previous financing agreements of KH-Koneet and Nordic Rescue Group [1] Strategic Implications - The refinancing of the entire Group and replacement of some short-term financing is expected to secure a solid financial foundation for long-term business development and support the company's growth [2] - The financing arrangement is viewed as a strategic move to enhance the operational capabilities of KH Group [2] Company Overview - KH Group Plc operates in two business areas: KH-Koneet, which supplies construction and earth-moving machinery, and Nordic Rescue Group, a manufacturer of rescue vehicles [3] - The company is listed on Nasdaq Helsinki and focuses on supporting sustainable construction and critical societal functions [3]

Core Insights - The report indicates a significant increase in AI adoption among contractors, with 38% reporting measurable business impact, up from 17% in 2025, highlighting a shift towards technology-driven operations [1][2] AI Adoption and Impact - AI is transitioning from experimentation to delivering real business results, with contractors applying it in high-value areas such as cost estimation (24%) and bid management (22%) [2] - AI is enhancing daily operations and decision-making rather than replacing core systems, with expectations for its role to expand throughout the project lifecycle [2] Market Conditions and Demand - Contractors are entering 2026 with steady demand, with 41% expressing optimism about market conditions and over three-quarters securing at least nine months of work [3] Cost Pressures - Rising labor and overhead costs, along with skilled labor shortages and increasing material prices, are impacting profitability, with 71% of contractors reporting rising wages, up from 55% in 2025 [4] Focus on Profitability - Contractors are prioritizing profitability, with 61% aiming to grow revenue through new projects and 45% focusing on increasing project margins [5] - To protect profits, 57% are improving billing timelines and 38% are managing labor costs closely [5] Cash Flow Management - Contractors are adopting proactive cash flow management strategies, with 67% using lines of credit for materials and 56% negotiating extended supplier terms [6] Change Orders and Documentation - Change orders are increasing project value by 5-20% for 59% of firms, emphasizing the need for better documentation and financial oversight [7] Technology Landscape - The technology landscape in commercial construction is fragmented, with only 20% of contractors using a single platform, indicating an opportunity for system consolidation and integrated platforms to enhance operational visibility [8]

Core Viewpoint - The company has officially changed its name from Jeffs' Brands Ltd to Nexera Technologies Ltd, reflecting a strategic shift towards advanced technologies and homeland security solutions [1][2][3] Company Rebranding - The name change is effective as of March 26, 2026, and the company's ordinary shares will begin trading under the new ticker symbol "NEXR" on March 31, 2026, replacing "JFBR" [2] - The rebranding initiative is part of a strategic repositioning to focus on homeland security technologies, AI-driven solutions, and advanced detection systems [2][3] Leadership Statement - The CEO of Nexera, Eliyahu Zamir, stated that the rebranding represents a significant milestone in the company's transformation and ambition to become a leading technology platform addressing global security challenges [3] Subsidiary Operations - The company is expanding its technology and security footprint through its subsidiary KeepZone AI Inc., which focuses on AI-driven threat detection and advanced screening technologies [4][6] - KeepZone AI Inc. is dedicated to distributing AI-powered homeland security technologies, including perimeter intrusion detection and counter-UAS systems [6] Legacy Operations - The company has divested its legacy consumer products operations, selling them to Fort Technology Inc. in July 2025, while retaining a controlling equity interest [6] - Ongoing e-commerce activities are maintained through other subsidiaries, primarily focused on data-driven online retail [6]

Core Insights - Immix Biopharma has completed enrollment for the NEXICART-2 trial, with topline results expected in Q3 2026, followed by a Biologics License Application (BLA) submission and planned commercial launch [1][2] - The company has appointed Richard Graydon, MD, PhD, as Chief Medical Officer, who has extensive experience in clinical development from Merck and Johnson & Johnson [2] - NXC-201, the lead candidate, is a CAR-T cell therapy targeting relapsed/refractory AL Amyloidosis and has received Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy designation from the FDA [6][8] Company Overview - Immix Biopharma, Inc. is a leader in the treatment of relapsed/refractory AL Amyloidosis, a disease characterized by the production of toxic light chains that lead to organ failure [7] - The company is focused on developing NXC-201, a CAR-T therapy designed to eliminate the source of toxic light chains [6][7] Clinical Trial Details - NEXICART-2 is a Phase 2 clinical trial involving 40 patients, designed to evaluate the efficacy of NXC-201 in treating relapsed/refractory AL Amyloidosis [3] - The trial has a registrational design, indicating its potential to support a BLA submission upon successful results [3] Market Insights - The AL Amyloidosis patient population in the U.S. is projected to grow at a rate of 12% annually, reaching approximately 38,500 patients by 2026 [4] - The market for AL Amyloidosis treatments was valued at $3.6 billion in 2017 and is expected to grow to $6 billion by 2025 [5]

Core Insights - The launch of the Bionic Intelligence Research Agent (BIRA) marks KALA BIO's transition into an operational AI infrastructure partner for the global biotechnology industry, delivering secure and scalable autonomous research solutions [1][15][21] - BIRA is powered by Researgent 2.0, a 70-billion-parameter large language model, designed specifically for the biotechnology and pharmaceutical sectors, ensuring next-generation performance within secure enterprise infrastructure [3][18] Deployment and Execution - KALA BIO successfully met its commitment to ship its first AI agent within 14 days, demonstrating its capability to deliver commercial-grade AI solutions at enterprise scale [2][4] - BIRA operates in client-controlled, VPN-secured environments, ensuring full data sovereignty and compliance with pharmaceutical R&D standards [5][18] Platform Capabilities - The platform features autonomous research execution, comprehensive database connectivity, and quality assurance with confidence scoring, enabling efficient research workflows [6][7][8] - BIRA's architecture is designed to scale with client organizations, supporting a platform-as-a-service model for recurring revenue [9][10][17] Product Roadmap - KALA BIO and Younet are developing four additional capabilities for BIRA, including automated research digests, real-time alerts, IP filings monitoring, and dormant IP identification [11][12][13] Strategic Significance - The launch of BIRA signifies a shift from platform readiness to live commercial deployment, creating an active revenue-generating opportunity for KALA BIO [15][16] - The company aims to maintain timely progress in building out the Researgency platform for market use, positioning itself at the forefront of the agentic transformation in biomedical research [4][21] Market Opportunity - BIRA is positioned to address significant market opportunities within the global biotechnology and pharmaceutical sectors, focusing on proprietary data control and enterprise-scale AI performance [18][19] - The platform's differentiation lies in its secure on-premises deployment model compared to public cloud AI options, enhancing its competitive positioning in the market [18][19]

Core Viewpoint - Baiya International Group Inc. has launched its Cryptocurrency Ark Plan, introducing a global voting mechanism to guide its digital asset allocation strategy, aiming for a structured and market-driven approach [1][9] Group 1: Global Voting Mechanism - The Company will conduct a one-week global vote from March 30, 2026, to April 5, 2026, focusing on two digital assets: Binance Coin (BNB) and Official Trump (TRUMP), representing contrasting value logics in the digital asset market [2] - The voting mechanism aims to transform internal decision-making into a transparent process, allowing market participants to influence asset allocation directly [3][6] Group 2: Execution and Management - Following the voting results, the Company plans to advance its digital asset acquisition and position management, evolving the Plan into a systematic mechanism for dynamic trading and value recirculation [4] - The Plan will adopt a disciplined trading management approach, with 50% of realized gains allocated to repurchasing shares, enhancing capital return and linking digital asset gains to shareholder value [5] Group 3: Value Formation and Market Integration - The Plan emphasizes not only asset selection but also the exploration of how value is formed in a market influenced by narrative, sentiment, and community participation [7][8] - The initiative aims to connect market participation with digital asset allocation and shareholder capital return, fostering integration between traditional capital markets and the crypto asset ecosystem [8]

Core Viewpoint - Clean Energy Technologies, Inc. (CETY) has signed a non-binding Letter of Intent (LOI) with Hoppy Power Ltd. to advance the deployment of its High Temperature Ablative Pyrolysis (HTAP) technology for waste-to-energy applications, marking a significant step towards commercialization [1][9]. Group 1: Project Development and Milestones - The initiative aims for near-term deployment and initial commercialization, with milestones in 2026 including engineering validation, permitting progression, and advancement towards definitive agreements [2][7]. - Westlock, Alberta has been identified as the initial site for potential deployment, chosen for its favorable access to feedstock and existing infrastructure [3][10]. - The project is designed to generate up to 2 MW of power per unit and process up to 12,000 tons per year of biomass and waste-derived feedstock [4][5]. Group 2: Commercial Viability and Revenue Streams - The modular system is expected to support multiple revenue streams, including waste processing fees, on-site power generation, and biochar production, positioning it competitively against conventional biomass solutions [6][9]. - The deployment model is designed to be scalable and repeatable across various markets, establishing a foundation for broader project rollouts [5][10]. Group 3: Technical and Operational Aspects - CETY will conduct technical evaluations, including feedstock analysis and preliminary engineering design, to support pilot deployment activities at the Westlock site [7][8]. - The advancement of the project is contingent on technical validation, feedstock availability, and securing necessary permits and regulatory approvals [8][10]. Group 4: Industry Engagement - CETY and Hoppy Power will participate in the International Biomass Conference & Expo to showcase their HTAP technology and explore strategic partnerships [11][12].

Key Information - Rathbones Group Plc disclosed a position in relevant securities representing 1% or more, specifically in relation to a consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited [1]. Positions of the Discloser - Rathbones Group Plc holds 85,467,150 ordinary shares in LondonMetric Property plc, representing 3.64% of the relevant securities [3]. - Additionally, Rathbones Group Plc holds 19,883,983 ordinary shares in Schroder Real Estate Investment Trust Limited, representing 4.06% of the relevant securities [4]. Dealings by the Discloser - Rathbones Group Plc executed multiple sales of LondonMetric 10p Ordinary Shares, including: - Sold 126,681 shares at 180.346p - Sold 4,565 shares at 178.15p - Sold 9,340 shares at 177.95p - Sold 14,250 shares at 177.8662p - Sold 3,000 shares at 178.6p - Sold 1,700 shares at 178.49p - Sold 3,200 shares at 178.766p - Sold 34,248 shares at 179.266p - Additionally, purchases of LondonMetric 10p Ordinary Shares included: - Purchased 378 shares at 178.834p - Purchased 22,400 shares at 177.85p - Purchased 346 shares at 177.85p - Purchased 14,250 shares at 177.9231p - Purchased 8,590 shares at 177.7433p - Purchased 3,000 shares at 178.6p - Purchased 16,310 shares at 178.834p [7]. - Rathbones Group Plc also sold 18,510 shares of Schroder REIT Ordinary NPV Shares at 46.1713p [7]. Other Information - There are no indemnity or other dealing arrangements disclosed by Rathbones Group Plc [12]. - There are no agreements, arrangements, or understandings relating to options or derivatives disclosed [13]. - The date of disclosure is 30/03/2026 [14].

Core Insights - Clearmind Medicine Inc. has successfully completed treatment and follow-up for 18 participants in its FDA-approved Phase I/IIa clinical trial for CMND-100, a non-hallucinogenic oral drug candidate aimed at treating Alcohol Use Disorder (AUD) [1][2][3] - The trial is progressing positively, with four additional participants treated at the Tel Aviv clinical site, indicating strong operational capabilities [2][3] Company Overview - Clearmind is a clinical-stage biotech company focused on developing non-hallucinogenic, neuroplastogen-derived therapeutics to address significant health issues, including AUD [4] - The company aims to research and commercialize psychedelic-based compounds as regulated medicines, foods, or supplements [4] Intellectual Property - Clearmind's intellectual property portfolio includes 19 patent families and 31 granted patents, with plans to seek additional patents as necessary [5]